Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain

The review analyzes the global experience in the application of nuclear medicine techniques for diagnosis of tumors and non-tumor pathologies of the brain. The main groups of radiopharmaceuticals currently used for imaging of malignant brain tumors and diagnosis of cognitive impairments and neurotra...

Full description

Bibliographic Details
Main Authors: R. V. Zelchan, A. A. Medvedeva, O. D. Bragina, A. N. Ribina, A. I. Ryabova, V. I. Chernov, E. L. Choynzonov
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2022-01-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/4590
_version_ 1797872823462526976
author R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
A. N. Ribina
A. I. Ryabova
V. I. Chernov
E. L. Choynzonov
author_facet R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
A. N. Ribina
A. I. Ryabova
V. I. Chernov
E. L. Choynzonov
author_sort R. V. Zelchan
collection DOAJ
description The review analyzes the global experience in the application of nuclear medicine techniques for diagnosis of tumors and non-tumor pathologies of the brain. The main groups of radiopharmaceuticals currently used for imaging of malignant brain tumors and diagnosis of cognitive impairments and neurotransmitter system disturbances by means of single-photon emission computed tomography and positron emission tomography are described.Modern approaches to the application of methods for radionuclide diagnosis in neuro-oncology and neurology are compared, and the main trends in production of new, more specific radiopharmaceuticals for visualizing brain tumors of various degrees of malignancy and diagnosing non-tumor pathologies of the brain are described. The review discusses the advantages and disadvantages of currently used techniques and radiopharmaceuticals for imaging of central nervous system disorders, depending on the clinical situation and specific diagnostic tasks.In addition, the review presents consolidated recommendations of the leading scientific schools in neuro-oncology on the use of nuclear medicine techniques in patients with brain tumors at the stages of treatment and follow-up. The presented article examines the experience of domestic scientific schools in the development of radiopharmaceuticals for neuro-oncology. The features of the development and use of new radiopharmaceuticals in patients with brain tumors and neurodegenerative diseases are highlighted. The review is based on the analysis of literature included in the Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, and RSCI databases.
first_indexed 2024-04-10T01:05:11Z
format Article
id doaj.art-512429c9d4db478f82738c7ba27ba01d
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:05:11Z
publishDate 2022-01-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-512429c9d4db478f82738c7ba27ba01d2023-03-13T09:58:27ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842022-01-0120413114210.20538/1682-0363-2021-4-131-1422849Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brainR. V. Zelchan0A. A. Medvedeva1O. D. Bragina2A. N. Ribina3A. I. Ryabova4V. I. Chernov5E. L. Choynzonov6Научно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наук; Национальный исследовательский Томский политехнический университет (НИ ТПУ)Научно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наукНаучно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наукНаучно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наук; Национальный исследовательский Томский политехнический университет (НИ ТПУ) 634050, г. Томск, пр. Ленина, 30Научно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наукНаучно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наук; Национальный исследовательский Томский политехнический университет (НИ ТПУ)Научно-исследовательский институт (НИИ) онкологии, Томский национальный исследовательский медицинский центр (НИМЦ) Российской академии наукThe review analyzes the global experience in the application of nuclear medicine techniques for diagnosis of tumors and non-tumor pathologies of the brain. The main groups of radiopharmaceuticals currently used for imaging of malignant brain tumors and diagnosis of cognitive impairments and neurotransmitter system disturbances by means of single-photon emission computed tomography and positron emission tomography are described.Modern approaches to the application of methods for radionuclide diagnosis in neuro-oncology and neurology are compared, and the main trends in production of new, more specific radiopharmaceuticals for visualizing brain tumors of various degrees of malignancy and diagnosing non-tumor pathologies of the brain are described. The review discusses the advantages and disadvantages of currently used techniques and radiopharmaceuticals for imaging of central nervous system disorders, depending on the clinical situation and specific diagnostic tasks.In addition, the review presents consolidated recommendations of the leading scientific schools in neuro-oncology on the use of nuclear medicine techniques in patients with brain tumors at the stages of treatment and follow-up. The presented article examines the experience of domestic scientific schools in the development of radiopharmaceuticals for neuro-oncology. The features of the development and use of new radiopharmaceuticals in patients with brain tumors and neurodegenerative diseases are highlighted. The review is based on the analysis of literature included in the Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, and RSCI databases.https://bulletin.ssmu.ru/jour/article/view/4590ядерная медицинаопухоль головного мозгадеменциярадионуклидная диагностикарадиофармацевтичекий препарат
spellingShingle R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
A. N. Ribina
A. I. Ryabova
V. I. Chernov
E. L. Choynzonov
Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
Бюллетень сибирской медицины
ядерная медицина
опухоль головного мозга
деменция
радионуклидная диагностика
радиофармацевтичекий препарат
title Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
title_full Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
title_fullStr Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
title_full_unstemmed Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
title_short Modern methods for radionuclide diagnosis of tumors and non-tumor pathologies of the brain
title_sort modern methods for radionuclide diagnosis of tumors and non tumor pathologies of the brain
topic ядерная медицина
опухоль головного мозга
деменция
радионуклидная диагностика
радиофармацевтичекий препарат
url https://bulletin.ssmu.ru/jour/article/view/4590
work_keys_str_mv AT rvzelchan modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT aamedvedeva modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT odbragina modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT anribina modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT airyabova modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT vichernov modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain
AT elchoynzonov modernmethodsforradionuclidediagnosisoftumorsandnontumorpathologiesofthebrain